EXTROVIS is a global pharmaceutical company based in Switzerland, offering a diverse portfolio including APIs (Active Pharmaceutical Ingredients), FDFs (Finished Dosage Forms) & Custom Pharmaceutical Services. The company has a strong presence in North America, India, and South America, supported by an extensive network for global product delivery.
EXTROVIS boasts state-of-the-art manufacturing facilities and R&D centers, adhering to the highest international quality standards with accreditations from the USFDA, PMDA, EU, and other global regulatory bodies. Additionally, the company has made meaningful contributions in education and healthcare for underprivileged communities, reinforcing its social commitment.
The company's mission is centered on becoming a reliable partner by providing high-quality APIs, FDFs, and custom pharmaceutical services, aiming to deliver value to customers, stakeholders, and patients. With its ambitious vision, EXTROVIS is positioned to emerge as a leading pharmaceutical company globally.